{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-114916","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2022-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.551346+00:00","generated_at":"2026-06-22T07:02:43.199374+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Avenue Therapeutics completes $3M share repurchase from InvaGen; two directors resign","bullets":["Completed $3M repurchase of InvaGen's 100% stake in Avenue, financed by public offering closed Oct 11, 2022.","Jaideep Gogtay, M.D. and E. Garrett Ingram resigned from Board and all committees effective Oct 31, 2022.","Resignations not due to any disagreement with Company, its operations, or management.","All rights granted to InvaGen under 2018 Stockholders Agreement terminated upon share repurchase."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-114916","json":"https://secwatch.observer/filing/0001104659-22-114916.json","markdown":"https://secwatch.observer/filing/0001104659-22-114916.md","text":"https://secwatch.observer/filing/0001104659-22-114916.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000110465922114916/0001104659-22-114916-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000110465922114916/tm2229761d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T07:02:43.199374+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"007ca222de","claim":"Jaideep Gogtay, M.D. resigned as Director at AVENUE THERAPEUTICS, INC..","evidence_excerpt":"each of Jaideep Gogtay, M.D. and E. Garrett Ingram, the two non-independent members of the Board originally selected by InvaGen, resigned as members of the Board and all committees thereof, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465922114916/0001104659-22-114916-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"2a8baf4036","claim":"E. Garrett Ingram resigned as Director at AVENUE THERAPEUTICS, INC..","evidence_excerpt":"each of Jaideep Gogtay, M.D. and E. Garrett Ingram, the two non-independent members of the Board originally selected by InvaGen, resigned as members of the Board and all committees thereof, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465922114916/0001104659-22-114916-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}